Work

A phase I study of a novel spectrum selective kinase inhibitor (SSKI), XL880, administered orally in patients (pts) with advanced solid tumors (STs)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.3041

Authors: J. P. Eder, L. Appleman, E. Heath, L. Malburg, A. Zhu, M. J. Pilat, G. Shapiro, P. Lorusso

Institutions: Massachusetts General Hospital, The Barbara Ann Karmanos Cancer Institute, Dana-Farber Cancer Institute

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2247544749

Cites:

Cited by: 20

Related to: 10